( February 5, 2026, 10:05 AM EST) -- LAFAYETTE, La. — Danco Laboratories LLC, the maker of Mifeprex brand of mifepristone, one of two drugs used to induce early termination of pregnancy, and GenBioPro Inc., the maker of generic mifepristone, moved separately in a Louisiana federal court to intervene in a case brought by the state that challenges the validity of the U.S. Food and Drug Administration’s 2023 decision to remove the in-person dispensing requirement for mifepristone, arguing that the federal government cannot adequately represent their interests....